Erratum: Author correction to ‘Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy’ [Acta Pharm Sin B 13 (2023) 1303–1317, (S2211383522003872), (10.1016/j.apsb.2022.08.024)]

Xueqin Huang, Bingbing Sheng, Hemi Tian, Qiuxia Chen, Yingqi Yang, Brian Bui, Jiang Pi, Huaihong Cai, Shanze Chen, Jianglin Zhang, Wei Chen, Haibo Zhou*, Pinghua Sun

*Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

The authors regret that there is an error in the article Fig. 4G due to the mistake of copying and pasting in the process of assembling figures and negligence in the proofreading. Although it does not affect the conclusion, it is an obvious error. The authors have now modified as below. The authors apologize for any inconvenience caused to the journal and readers. The original Fig. 4G was:[Formula presented] Fig.

Original languageEnglish
Pages (from-to)4338-4340
Number of pages3
JournalActa Pharmaceutica Sinica B
Volume13
Issue number10
DOIs
Publication statusPublished - Oct 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Erratum: Author correction to ‘Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy’ [Acta Pharm Sin B 13 (2023) 1303–1317, (S2211383522003872), (10.1016/j.apsb.2022.08.024)]'. Together they form a unique fingerprint.

Cite this